Vipin Arora
- Genetics top 5%
- Inflammatory Bowel Disease 35
- Gastroenterology top 5%
- Celiac Disease Research and Management 10
- Epidemiology top 10%
- Microscopic Colitis 32
- Autoimmune and Inflammatory Disorders 3
-
- IL-33, ST2, and ILC Pathways 3
- Ophthalmology top 5%
-
- Liver Diseases and Immunity 4
-
- Eosinophilic Esophagitis 3
-
- Colorectal Cancer Treatments and Studies 3
- Co-authors
- Toshifumi Hibi∥Geert D’HaensMarla C. DubinskyNathan MorrisBruce E. SandsRoopal ThakkarWilliam J. SandbornTaku Kobayashi
- Cited by
- GeneticsGastroenterologyEpidemiology
- Journals
- New England Journal of Medicine (1 paper)Journal of the American Statistical Association (2 papers)Gastroenterology (11 papers)
- Partner nations
- United StatesJapanCanada
In The Last Decade
Vipin Arora
38 papers receiving 740 citations
Hit Papers
Peers
Comparison fields: 5 of 76
- Genetics 563
- Gastroenterology 72
- Epidemiology 452
- Immunology 153
- Ophthalmology 64
Countries citing papers authored by Vipin Arora
This map shows the geographic impact of Vipin Arora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vipin Arora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vipin Arora more than expected).
Fields of papers citing papers by Vipin Arora
This network shows the impact of papers produced by Vipin Arora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vipin Arora. The network helps show where Vipin Arora may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Vipin Arora, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 26 | |
| 2 | 2024 | 5 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 8 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 1 | |
| 8 | Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitisbreakdown → | 2023 | 170 |
| 9 | 2022 | 1 | |
| 10 | 2022 | 15 | |
| 11 | 2022 | 48 | |
| 12 | 2020 | 1 | |
| 13 | 2020 | 1 | |
| 14 | 2020 | 5 | |
| 15 | 2019 | 1 | |
| 16 | 2014 | 71 | |
| 17 | 2014 | 31 | |
| 18 | 2013 | 133 | |
| 19 | 2000 | 39 | |
| 20 | 1997 | 20 |
About Vipin Arora
Vipin Arora is a scholar working on Gastroenterology, Genetics and Epidemiology, having authored 40 papers that have together received 763 indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (35 papers), Microscopic Colitis (32 papers), Celiac Disease Research and Management (10 papers), Liver Diseases and Immunity (4 papers), Eosinophilic Esophagitis (3 papers), IL-33, ST2, and ILC Pathways (3 papers), Colorectal Cancer Treatments and Studies (3 papers) and Autoimmune and Inflammatory Disorders (3 papers). The work is most often cited by research in Genetics (563 citations), Gastroenterology (72 citations) and Epidemiology (452 citations). Vipin Arora has collaborated with scholars based in United States, Japan and Canada. Frequent co-authors include Toshifumi Hibi∥, Geert D’Haens, Marla C. Dubinsky, Nathan Morris, Bruce E. Sands, Roopal Thakkar, William J. Sandborn, Taku Kobayashi, April N. Naegeli and Mamoru Watanabe. Their work appears in journals such as New England Journal of Medicine, Journal of the American Statistical Association and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.